← Back to Search

Shoonya Meditation for Sleep Deprivation (REST Trial)

N/A
Recruiting
Led By Balachundhar Subramaniam, MD, MPH
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months post learning meditation
Awards & highlights

REST Trial Summary

This trial looks at how a 15-minute meditation affects sleep and heart rate variability, as well as cognition, after both a good night's sleep and a bad one.

Who is the study for?
This trial is for healthy adults over 18 living in the US who either practice Shoonya meditation or nap regularly. They must be able to travel to Boston and not have a history of psychiatric disorders, substance abuse, major neurological conditions, sleep disorders, heart issues, or consume excessive caffeine.Check my eligibility
What is being tested?
The study examines how a 15-minute Shoonya meditation affects sleep patterns and cognitive performance after both restful sleep and sleep deprivation compared to regular nappers. It also looks at changes in heart rate variability linked with high-frequency brain activity.See study design
What are the potential side effects?
Since this trial involves meditation practices and napping without any pharmaceutical intervention, there are no direct side effects associated with these activities as they are generally considered safe.

REST Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months post learning meditation
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months post learning meditation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Error frequency Change: Go-No Go Task
Secondary outcome measures
Reaction Time Change: Go-No Go

REST Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: Control MeditatorsActive Control1 Intervention
Control subjects will be individuals that have learned the prerequisite meditation to Shoonya meditation. This meditation is called Shambhavi Mahamudra Kriya. Control subjects will not learn Shoonya meditation while they are participating in the study. One weekend of data collection will occur at baseline.
Group II: Shoonya MeditatorsActive Control1 Intervention
This is intervention arm. Participants will learn and practice the fifteen minute shoonya meditation - described as a process of conscious non-doing- and shakti chalana kriya, which is a set of breathing exercises designed as a preparatory practice to shoonya meditation. Participants will practice shoonya meditation twice a day for two months. A weekend of data collection will happen at baseline and two months after they learn the practice.
Group III: Nap PractitionersPlacebo Group1 Intervention
This is an observational arm of regular nappers. Individuals that take naps at least two times a week will be invited to undergo all of the study procedures for one weekend of data collection.

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor
837 Previous Clinical Trials
13,010,212 Total Patients Enrolled
6 Trials studying Sleep Deprivation
4,434 Patients Enrolled for Sleep Deprivation
Balachundhar Subramaniam, MD, MPHPrincipal InvestigatorBeth Israel Deaconess Medical Center
7 Previous Clinical Trials
9,776 Total Patients Enrolled

Media Library

Shoonya Meditators Clinical Trial Eligibility Overview. Trial Name: NCT05026541 — N/A
Sleep Deprivation Research Study Groups: Control Meditators, Shoonya Meditators, Nap Practitioners
Sleep Deprivation Clinical Trial 2023: Shoonya Meditators Highlights & Side Effects. Trial Name: NCT05026541 — N/A
Shoonya Meditators 2023 Treatment Timeline for Medical Study. Trial Name: NCT05026541 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is participation in this research study widespread?

"Affirmative, the clinicaltrials.gov records indicate that this medical research currently requires participants. This trial was initially published on September 12th 2022 and recently updated on September 23rd 2022. The study demands 60 test subjects from one location."

Answered by AI

Could I potentially qualify to partake in this medical experiment?

"Prospective participants should be aged between 18 and 60, have a history of sleep debt, and meet the other inclusion criteria. Approximately sixty patients are needed to complete this trial."

Answered by AI

Are there any openings available for enrolment in this trial?

"As indicated by the records on clinicaltrials.gov, this medical trialis actively recruiting participants. The original posting was made on September 12th 2022 and it underwent a recent update in late September of this year."

Answered by AI

Is the study allowing for participation from individuals over a certain age?

"This clinical trial has established the lower age limit for enrollment to be 18, while the upper limit is restricted to 60."

Answered by AI

What aims does this trial seek to achieve?

"The principal goal of this trial, to be assessed within two months after participants learn meditation, is Reaction Time Change- Go-No Go Task. Secondary objectives encompass Stanford Sleepiness Scale (SSS) change; Correct Word Pairs Change - Word-Pair Memory Consolidation; and Sleep Architecture change- Wake after sleep onset."

Answered by AI
~18 spots leftby Dec 2024